Journal profile · PHARMACOLOGY & PHARMACY
Indonesian Journal of Pharmacy
ISSN 2338-9486 · eISSN 2338-9427 · Universitas Gadjah Mada · Indonesia
Indonesian Journal of Pharmacy: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 200; review about 12 weeks (community reports); 71 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Indonesian Journal of Pharmacy is published by Universitas Gadjah Mada and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medicinal Plant Research, Natural Antidiabetic Agents Studies and Drug Solubulity and Delivery Systems, together about 25.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The journal includes various fields of pharmaceuticals sciences such as: -Pharmacology and Toxicology -Pharmacokinetics -Community and Clinical Pharmacy -Pharmaceutical Chemistry -Pharmaceutical Biology -Pharmaceutics -Pharmaceutical Technology -Biopharmaceutics -Pharmaceutical Microbiology and Biotechnology -Alternative medicines
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Marlyn Dian LaksitoriniPublisher website
Editorial board by country: none in mainland China; most named Indonesia 2, Canada 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medicinal Plant ResearchAgricultural and Biological Sciences9.6%
- Natural Antidiabetic Agents StudiesMedicine8%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.7%
- Computational Drug Discovery MethodsComputer Science6.8%
- Analytical Methods in PharmaceuticalsChemistry6.2%
- Synthesis and biological activityChemistry5.9%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.9%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Google Scholar, EBSCO, Dimensions, DIMENSION, Google Schoolar, SINTA, Index Copernicus, GetCITED, Genamics JournalSeek (New Jersey, USA), Geneva Foundation for Medical Education and Research (GFMER), Pharmaceutical Sciences Open Access Resources (PSOAR), International Pharmaceutical Abstracts (IPA), UGM Digital Library, WorldCat, Virtual Library (Pharmacy Page), EBSCO Publishing Database, CAB International, Socolar, SCIRUS Elsevier, Indonesian Scientific Journal Database (ISJD)Publisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.22LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 19OpenAlex ·
- i10-index
- 58OpenAlex ·
- 2-year mean citedness
- 0.58OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 31.58%LetPub ·
Volume
- Articles per year
- 66LetPub ·
Articles by year OpenAlex count · 806 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 41 | 4 |
| 2025 | 71 | 71 | 32 |
| 2024 | 56 | 56 | 62 |
| 2023 | 62 | 62 | 97 |
| 2022 | 67 | 67 | 247 |
| 2021 | 57 | 57 | 257 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 9 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 200 | No | CC BY | |
| OpenAlex | USD 200 | — | — | |
| LetPub | USD 200 | No | — | |
| Publisher website | USD 320 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 200–300 words
- Keywords
- ≥ 3
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted3, with length limits
- research articleResearch ArticleLength not stated
- review articleThe Perspectives of DM Patients About Barriers to Using Digital Health Technology in Qualitative Study: A Systematic Review Anita Kumala Hati, Susi Ari Kristina…Length not stated
- short communicationgures and tables from published papers. Short communications – The length of the communications should be up to 1500 words, describing work that may be of a pre…main text ≤ 1,500 words
Policy excerpts from the journal's websitePublication ethics, Open access
- Publication ethics PUBLICATION ETHICS
Publication Ethics and Malpractice StatementIndonesian Journal of Pharmacy (Indonesian J. Pharm.) is an international peer-reviewed journal. This statement clarifies ethical conduct to all parties involved in manuscript publication Indonesian J. Pharm, including the author(s), Editor in Chief, the Editorial Board, the peer-reviewer, and the publisher (Faculty of Pharmacy, Gadjah Mada University). …
Source ↗Publisher website ·- Open access OPEN ACCESS POLICY
Immediate open access on the principle that making research freely available supports a greater global exchange of knowledge. Model summary
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Universitas Gadjah Mada
- Country or region
- Indonesia
- Language
- English
- ISSN
- 2338-9486
- Print ISSN
- 0126-1037
- Electronic ISSN
- 2338-9427
- Latest issue on the website
- Volume 37, Issue 3 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Indonesian Journal of Pharmacy
What CAS zone is Indonesian Journal of Pharmacy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indonesian Journal of Pharmacy is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Indonesian Journal of Pharmacy?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Indonesian Journal of Pharmacy?
According to the journal's author guidelines: Abstract: 200–300 words; Keywords: ≥ 3; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Indonesian Journal of Pharmacy based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Indonesia (2) and Canada (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Indonesian Journal of Pharmacy?
According to LetPub and DOAJ records, Indonesian Journal of Pharmacy is indexed in ESCI, Scopus and DOAJ.
Is Indonesian Journal of Pharmacy open access, and what is the APC?
Indonesian Journal of Pharmacy is a fully open-access journal. APC about USD 200.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .